Peter Attia· MD
my bio engineering colleagues being able to collaborate with me and develop a device that we can transcranial II do imaging with near-infrared spectroscopy and actually measure the concentrations of oxidized cytochrome oxidase in vivo in the human brain and we published that last year and this allows us to directly have a measurement that we are indeed engaging our target and this also will allow us to find what is the optimal dose response for that particular brain